Water can penetrate the polymer matrix and reach bonds that are susceptible to hydrolysis, meaning cleavage caused by water. As those bonds break, the material can progressively lose mass and mechanical strength. This change is clinically important because a device must remain functional for the needed period, then decline as healing or treatment requirements change.
Enzymes and cellular processes may also contribute to degradation alongside water-driven chemical cleavage. Their involvement means that material loss can reflect both reactions within the polymer matrix and biological activity around it. Considering these contributors helps clinicians and developers judge whether the material will retain its intended role over time.
The degradation rate should correspond to the healing process and the device's intended clinical function. If material changes too quickly or too slowly relative to those requirements, its loss of mass and mechanical strength may not align with the period of support needed. Matching these characteristics is therefore central to clinical material selection.
Clinical suitability depends on more than whether the material eventually breaks down. The relevant considerations include degradation rate, the nature of degradation byproducts, retention of mechanical strength, and biocompatibility. Assessing these properties together helps align the polymer with a healing process, temporary device function, or other intended clinical use.
Temporary sutures illustrate a use in which material persistence is not intended indefinitely. A biodegradable polymer can provide the suture function while its degradation causes progressive loss of mass and mechanical strength. The clinically relevant question is whether those changes correspond to the period during which the tissue requires support.
In clinical design, the polymer's degradation rate, byproducts, mechanical strength, and biocompatibility can be considered together when selecting it for a drug-delivery system. These criteria help determine whether the material's temporary presence is compatible with the intended treatment period and biological setting, without requiring long-term persistence after its function is completed.
Tissue-engineering scaffolds and absorbable medical devices are applications where long-term material persistence may be undesirable. For these uses, researchers must consider how water, biological activity, and chemical processes affect the polymer over time. Degradation rate, byproducts, strength, and biocompatibility then provide the main criteria for matching the material to its clinical role.